Clorox CO /DE/ Form 4 insider transactions
NYSE
Director Russell J. Weiner reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.
NYSE
Director Kathryn Tesija reports acquiring deferred stock units in Clorox through dividend reinvestment and in lieu of quarterly director's fees.
NYSE
Director Matthew J. Shattock reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.
NYSE
Director Stephanie Plaines reports acquisition of deferred stock units in The Clorox Company through dividend reinvestment and in lieu of quarterly director's fees.
NYSE
Director Spencer C. Fleischer reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.
NYSE
Director Christopher J. Williams reports acquiring and disposing of Clorox common stock, along with acquiring deferred stock units through dividend reinvestment.
NYSE
Director Paul Gray Parker increased his holdings in Clorox through stock acquisition and dividend reinvestment in deferred stock units.
NYSE
Director Amy Banse reports acquiring and disposing of Clorox (CLX) common stock and deferred stock units.
NYSE
Chris T. Hyder, a Group President at Clorox, reported a transaction involving common stock on March 14, 2024, to satisfy tax obligations related to vesting restricted stock.
NYSE
Stacey Grier, Executive Chief of Staff at Clorox, reports a transaction involving common stock to cover tax obligations.